Troglitazone Induces Extracellular Matrix and Cytoskeleton Remodeling in Mouse Collecting Duct Cells
Figure 5
Troglitazone attenuates β-catenin expression in IMCD-K2 and M1 cells. IMCD-K2, and M1 cells were treated with DMSO (vehicle) or troglitazone (TRO), and in (a) a representative Western blot is shown for β-catenin and corresponding β-actin. In (b) the corresponding densitometric analysis is shown with data presented as mean ± S.E.M. (*). In (c) a densitometric analysis of β-catenin is shown for M1 cells treated with 10 μM TRO in the presence or absence of the PPARγ antagonists GW9662 and T0070907.
